Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what estimate he has made of the likely annual cost to the NHS of treating age-related macular degeneration by 2050.
From the data collected it is not possible to identify how much was spent specifically on treating patients with age-related macular degeneration.
No estimate has been made of the annual cost of treating age related macular degeneration by 2050.